PTC Therapeutics closed a $60 million senior secured term loan with MidCap Financial as administrative agent. According to a related 8-K filing, the company drew $40 million at closing.

The remaining $20 million will become available to the company upon its demonstration (on or prior to December 31, 2018) of net product revenue equaling or exceeding $120 million for the trailing 12 month period.